Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-1,995
Closed -$73K 1029
2020
Q2
$73K Sell
1,995
-4,220
-68% -$112K ﹤0.01% 996
2020
Q1
$106K Sell
6,215
-4,716
-43% -$150K ﹤0.01% 968
2019
Q4
$458K Hold
10,931
﹤0.01% 898
2019
Q3
$303K Buy
10,931
+1,995
+22% +$48.3K ﹤0.01% 950
2019
Q2
$176K Buy
+8,936
New +$207K ﹤0.01% 996
2014
Q4
Sell
-613,424
Closed -$7.72M 1324
2014
Q3
$7.72M Sell
613,424
-1,694,094
-73% -$25.4M 0.03% 695
2014
Q2
$34.7M Sell
2,307,518
-2,340,602
-50% -$34.9M 0.1% 236
2014
Q1
$72.5M Sell
4,648,120
-1,801,168
-28% -$27.6M 0.21% 122
2013
Q4
$103M Sell
6,449,288
-711,683
-10% -$9.48M 0.29% 86
2013
Q3
$97.5M Buy
7,160,971
+2,076,830
+41% +$30.1M 0.29% 88
2013
Q2
$83.9M Buy
+5,084,141
New +$82.4M 0.26% 102

Other funds holding CROX

Royce & Associates's CROX Position: Q3 2020 in Review

Royce & Associates sold out of Crocs (CROX) in Q3 2020, closing a stake of 1,995 shares — an estimated $73K sold.

Royce & Associates first reported a position in CROX in Q2 2013 and held it in 11 quarters. The position peaked at $103M in Q4 2013. 234 funds tracked by Wall St. Rank hold CROX as of Q3 2020.

  • Royce & Associates reported no remaining Crocs position as of Q3 2020 after selling out during the quarter.
  • Royce & Associates sold 1,995 Crocs shares in Q3 2020, an estimated $73K.
  • Royce & Associates first reported a position in Crocs in Q2 2013 and held it in 11 quarters.
  • Royce & Associates's Crocs position peaked at $103M in Q4 2013.
  • 234 funds tracked by Wall St. Rank held Crocs as of Q3 2020.

Based on Royce & Associates's 13F filing for Q3 2020, filed 12 Nov 2020.